SCHEMBL5720568

SCHEMBL5720568

ClC(Cl)(Cl)c1ccnc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.50
MAPT P10636 3/20 0.47
KDM4E B2RXH2 3/20 0.47
CYP1A2 P05177 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MAPK1 P28482 2/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
HTR1A P08908 2/20 0.44
ADRA1D P25100 2/20 0.44
ADRA1A P35348 2/20 0.44
ADRA1B P35368 2/20 0.44
PDE4A P27815 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27991410 0.86 MAPT (0.52) NCF1MAPTKDM4ECYP1A2ALDH1A1
Hydrochloric Acid SCHEMBL7348696 0.82 NCF1 (0.46) NCF1MAPTKDM4ECYP1A2ALDH1A1
SCHEMBL11856121 0.81 NCF1 (0.44) NCF1MAPTKDM4ECYP1A2ALDH1A1
SCHEMBL5720366 0.81 NCF1 (0.52) NCF1MAPTKDM4ECYP1A2ALDH1A1
SCHEMBL803131 0.79 NCF1 (0.50) NCF1MAPTKDM4ECYP1A2ALDH1A1
SCHEMBL826351 0.79 BACE1 (0.50) NCF1MAPTKDM4ECYP1A2ALDH1A1
Ammonia Solution, Strong SCHEMBL11973873 0.78 BACE1 (0.49) NCF1MAPTKDM4ECYP1A2ALDH1A1
SCHEMBL7356796 0.76 NCF1 (0.47) NCF1MAPTKDM4ELOXL2HTR1A
SCHEMBL264501 0.76 NCF1 (0.52) NCF1MAPTKDM4EALDH1A1HPGD
SCHEMBL16252851 0.76 NCF1 (0.52) NCF1MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 US disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 US disclosed
EP-1072576-B1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2006-08-02 EP disclosed
US-6417361-B1 HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND MITSUI CHEMICALS, INC. (JP) 2002-07-09 US disclosed
CN-1294568-A Fluorinating agent, process for producing same, and use thereof MITSUI CHEMICALS INC (JP) 2001-05-09 CN disclosed
EP-1072576-A1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2001-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 NCF1 148/4885MAPT 729/4885KDM4E 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.